Skip to main content
Top
Published in: Clinical & Experimental Metastasis 2/2010

01-02-2010 | Review

Protracted disseminated skeletal metastases from angiosarcoma of the spleen

Authors: B. Jobke, M. Werner, G. Jundt, H. Ostertag, J. Freyschmidt

Published in: Clinical & Experimental Metastasis | Issue 2/2010

Login to get access

Abstract

Angiosarcomas are high-grade vascular tumors associated with poor prognosis due to their aggressive nature. Occasional skeletal manifestations present commonly as osteolytic destruction. The 55-years-old patient presented in this case report had a disease-free 4 years interval between splenectomy after primary angiosarcoma of the spleen and an unusual skeletal metastatic pattern mimicking benign angiomatosis. Despite lacking radiographic evidence for a highly aggressive osseous process, the histopathological resemblance of the bone biopsy with the primary tumor manifestation and the fulminant course of disease after onset of disseminated osseous spread confirmed the malignant character of the vascular tumor. The case demonstrates the highly variable radiographic pattern and particular pathobiological behavior of vascular malignancies.
Literature
1.
go back to reference Wenger DE, Wold LE (2000) Malignant vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol 29:619–631CrossRefPubMed Wenger DE, Wold LE (2000) Malignant vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol 29:619–631CrossRefPubMed
2.
go back to reference Autry JR, Weitzner S (1975) Hemangiosarcoma of spleen with spontaneous rupture. Cancer 35:534–539CrossRefPubMed Autry JR, Weitzner S (1975) Hemangiosarcoma of spleen with spontaneous rupture. Cancer 35:534–539CrossRefPubMed
3.
go back to reference Chen KT, Bolles JC, Gilbert EF (1979) Angiosarcoma of the spleen: a report of two cases and review of the literature. Arch Pathol Lab Med 103:122–124PubMed Chen KT, Bolles JC, Gilbert EF (1979) Angiosarcoma of the spleen: a report of two cases and review of the literature. Arch Pathol Lab Med 103:122–124PubMed
4.
go back to reference Lomasney LM, Martinez S, Demos TC, Harrelson JM (1996) Multifocal vascular lesions of bone: imaging characteristics. Skeletal Radiol 25:255–261CrossRefPubMed Lomasney LM, Martinez S, Demos TC, Harrelson JM (1996) Multifocal vascular lesions of bone: imaging characteristics. Skeletal Radiol 25:255–261CrossRefPubMed
5.
go back to reference Freyschmidt J, Ostertag H, Sternberg A (2006) Skeletal hemangiomatosis—evaluation of 15 new cases. Skeletal Radiol 35:419 (Abstract) Freyschmidt J, Ostertag H, Sternberg A (2006) Skeletal hemangiomatosis—evaluation of 15 new cases. Skeletal Radiol 35:419 (Abstract)
6.
go back to reference Falk S, Krishnan J, Meis JM (1993) Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol 17:959–970PubMedCrossRef Falk S, Krishnan J, Meis JM (1993) Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol 17:959–970PubMedCrossRef
7.
go back to reference Wang C, Rabah R, Blackstein M, Riddell RH (2004) Bone marrow metastasis of angiosarcoma. Pathol Res Pract 200:551–555CrossRefPubMed Wang C, Rabah R, Blackstein M, Riddell RH (2004) Bone marrow metastasis of angiosarcoma. Pathol Res Pract 200:551–555CrossRefPubMed
8.
go back to reference Hsu JT, Chen HM, Lin CY, Yeh CN, Hwang TL, Jan YY, Chen MF (2005) Primary angiosarcoma of the spleen. J Surg Oncol 92:312–316CrossRefPubMed Hsu JT, Chen HM, Lin CY, Yeh CN, Hwang TL, Jan YY, Chen MF (2005) Primary angiosarcoma of the spleen. J Surg Oncol 92:312–316CrossRefPubMed
9.
go back to reference Gutierrez RM, Spjut HJ (1972) Skeletal angiomatosis: report of three cases and review of the literature. Clin Orthop Relat Res 85:82–97CrossRefPubMed Gutierrez RM, Spjut HJ (1972) Skeletal angiomatosis: report of three cases and review of the literature. Clin Orthop Relat Res 85:82–97CrossRefPubMed
10.
go back to reference Ritchie G, Zeier FG (1956) Hemangiomatosis of the skeleton and the spleen. J Bone Joint Surg Am 38-A:115–122PubMed Ritchie G, Zeier FG (1956) Hemangiomatosis of the skeleton and the spleen. J Bone Joint Surg Am 38-A:115–122PubMed
11.
go back to reference Boyle WJ (1972) Cystic angiomatosis of bone. A report of three cases and review of the literature. J Bone Joint Surg Br 54:626–636PubMed Boyle WJ (1972) Cystic angiomatosis of bone. A report of three cases and review of the literature. J Bone Joint Surg Br 54:626–636PubMed
12.
go back to reference Hermann GG, Fogh J, Graem N, Hansen OP, Hippe E (1984) Primary hemangiosarcoma of the spleen with angioscintigraphic demonstration of metastases. Cancer 53:1682–1685CrossRefPubMed Hermann GG, Fogh J, Graem N, Hansen OP, Hippe E (1984) Primary hemangiosarcoma of the spleen with angioscintigraphic demonstration of metastases. Cancer 53:1682–1685CrossRefPubMed
13.
go back to reference Wenger DE, Wold LE (2000) Benign vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol 29:63–74CrossRefPubMed Wenger DE, Wold LE (2000) Benign vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol 29:63–74CrossRefPubMed
14.
go back to reference Ishida T, Dorfman HD, Steiner GC, Norman A (1994) Cystic angiomatosis of bone with sclerotic changes mimicking osteoblastic metastases. Skeletal Radiol 23:247–252CrossRefPubMed Ishida T, Dorfman HD, Steiner GC, Norman A (1994) Cystic angiomatosis of bone with sclerotic changes mimicking osteoblastic metastases. Skeletal Radiol 23:247–252CrossRefPubMed
15.
go back to reference Daldrup-Link HE, Henning T, Link TM (2007) MR imaging of therapy-induced changes of bone marrow. Eur Radiol 17:743–761CrossRefPubMed Daldrup-Link HE, Henning T, Link TM (2007) MR imaging of therapy-induced changes of bone marrow. Eur Radiol 17:743–761CrossRefPubMed
16.
go back to reference Campanacci M, Boriani S, Giunti A (1980) Hemangioendothelioma of bone: a study of 29 cases. Cancer 46:804–814CrossRefPubMed Campanacci M, Boriani S, Giunti A (1980) Hemangioendothelioma of bone: a study of 29 cases. Cancer 46:804–814CrossRefPubMed
17.
go back to reference Clifford CA, Mackin AJ, Henry CJ (2000) Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14:479–485CrossRefPubMed Clifford CA, Mackin AJ, Henry CJ (2000) Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14:479–485CrossRefPubMed
18.
go back to reference Fraiman G, Ganti AK, Potti A, Mehdi S (2003) Angiosarcoma of the small intestine: a possible role for thalidomide? Med Oncol 20:397–402CrossRefPubMed Fraiman G, Ganti AK, Potti A, Mehdi S (2003) Angiosarcoma of the small intestine: a possible role for thalidomide? Med Oncol 20:397–402CrossRefPubMed
20.
go back to reference Roe FJ, Walters MA (1968) Sensitivity of newborn mice to carcinogenic agents. Food Cosmet Toxicol 6:581–582CrossRefPubMed Roe FJ, Walters MA (1968) Sensitivity of newborn mice to carcinogenic agents. Food Cosmet Toxicol 6:581–582CrossRefPubMed
21.
go back to reference Tan DS, Evanson J, Plowman PN, Chew SL (2004) Post-radiation inflammatory reaction controlled with thalidomide and rofecoxib. Clin Oncol (R Coll Radiol) 16:585–586 Tan DS, Evanson J, Plowman PN, Chew SL (2004) Post-radiation inflammatory reaction controlled with thalidomide and rofecoxib. Clin Oncol (R Coll Radiol) 16:585–586
Metadata
Title
Protracted disseminated skeletal metastases from angiosarcoma of the spleen
Authors
B. Jobke
M. Werner
G. Jundt
H. Ostertag
J. Freyschmidt
Publication date
01-02-2010
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 2/2010
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-010-9308-1

Other articles of this Issue 2/2010

Clinical & Experimental Metastasis 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine